Gossamer Bio, Inc.
GOSS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728117
No open-market purchases or sales by Gossamer Bio, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $60.8M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q2 2021 vs. Q1 2021
How the institutions holding Gossamer Bio, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 123 | 115 | −8 |
| Shares | 54.3M | 53.1M | −1.17M (−2.2%) |
| Value | $501.9M | $431.1M | −$70.8M (−14.1%) |
New holders (17)
Institutions that held Gossamer Bio, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 1,175,000 | $9.54M | 2.68% |
| Farallon Capital Management, L.L.C. | 202,326 | $1.64M | 0.01% |
| Nisa Investment Advisors, LLC | 41,750 | $339.0K | 0.00% |
| ExodusPoint Capital Management, LP | 37,543 | $305.0K | 0.00% |
| Jane Street Group, LLC | 20,217 | $164.0K | 0.00% |
| Qube Research & Technologies Ltd | 13,271 | $108.0K | 0.00% |
| Texas Yale Capital Corp. | 10,000 | $81.0K | 0.00% |
| State of Wyoming | 4,761 | $39.0K | 0.02% |
| SG3 Management, LLC | 2,000 | $16.0K | 0.01% |
| Cutler Group LP | 1,500 | $12.0K | 0.00% |
| Alaethes Wealth LLC | 750 | $6.00K | 0.00% |
| Sandy Spring Bank | 300 | $2.00K | 0.00% |
| Laurel Wealth Advisors LLC | 200 | $2.00K | 0.00% |
| Aspire Private Capital, LLC | 200 | $2.00K | 0.00% |
| Salem Investment Counselors Inc | 100 | $1.00K | 0.00% |
| Group One Trading, L.P. | 100 | $1.00K | 0.00% |
| Advisory Services Network, LLC | 40 | $0 | 0.00% |
Sold out (25)
Institutions that held Gossamer Bio, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.